Alphageneron Pharmaceuticals announced it raised $250,000 in an initial filing from an offering of $250,000

Company

Location

About

Alphageneron Pharmaceuticals Inc., (“Alphageneron”) is a private clinical stage biopharmaceutical company advancing Natural Killer Cell (“NK Cell”) immunotherapies for hematologic cancers or solid tumors; and, viral infections (including COVID-19). Our seasoned team of biopharmaceutical executives, scientists and clinicians, in the United States and Europe, bringing decades of experience, will be an integral element to the success of our Company.